Exelon capsules
- Name:
Exelon capsules
- Company:
Novartis Ireland Limited
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 09/05/19
(Click to Download)Click on this link to Download PDF directly
Novartis Ireland Limited
Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 9 May 2019 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
Updated on 8 April 2019 SmPC
Reasons for updating
- File format updated to PDF
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 22 January 2019 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - marketing authorisation number
Updated on 21 May 2018 SmPC
Reasons for updating
- Change to MA holder contact details
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Address change BREXIT
Updated on 8 February 2018 SmPC
Reasons for updating
- New SmPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 8 February 2018 SmPC
Reasons for updating
- Improved presentation of SPC
- Change from individual to joint SPC
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updated on 19 May 2016 PIL
Reasons for updating
- New PIL for new product
Updated on 19 May 2016 PIL
Reasons for updating
- Change to warnings or special precautions for use
Updated on 3 September 2015 PIL
Reasons for updating
- Change to MA holder contact details
- Addition of information on reporting a side effect.
Updated on 28 April 2015 PIL
Reasons for updating
- Change to warnings or special precautions for use
Updated on 14 March 2014 PIL
Reasons for updating
- Removal/change of distributor
Updated on 28 May 2013 PIL
Reasons for updating
- Change to further information section
Updated on 6 March 2013 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to storage instructions
- Correction of spelling/typing errors
Updated on 5 March 2013 PIL
Reasons for updating
- Change to, or new use for medicine
- Change to warnings or special precautions for use
- Change to storage instructions
- Change to information about pregnancy or lactation
Updated on 26 September 2012 PIL
Reasons for updating
- Addition of information on alternative format leaflets
Updated on 8 August 2012 SmPC
Reasons for updating
- Change to section 10 - Date of revision of the text
- Joint SPC superseded by SPCs for individual presentations
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updated on 16 April 2009 PIL
Reasons for updating
- Change to side-effects
Updated on 24 February 2009 SmPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updated on 3 September 2008 SmPC
Reasons for updating
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.7 - Effects on ability to drive and use machines
- Change to section 9 - Date of renewal of authorisation
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updated on 10 November 2006 SmPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Update to Sections 4.4 and 4.8 of the SPC and section 4 of the PIL in relation to vomiting associated with oesophageal rupture and elevated liver function tests.
In addition, some clarifications have been introduced in section 5.1 of the SPC
Updated on 18 May 2006 PIL
Reasons for updating
- Change to, or new use for medicine
Updated on 31 March 2006 SmPC
Reasons for updating
- Change to section 4.1 - Therapeutic indications
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 25 August 2004 PIL
Reasons for updating
- New PIL for medicines.ie
Updated on 10 July 2003 SmPC
Reasons for updating
- Change to section 3 - Pharmaceutical form
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.8 - Undesirable effects
- Change to section 6.1 - List of excipients
- Change to section 9 - Date of renewal of authorisation
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 30 June 2003 SmPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Product subject to medical prescription which may not be renewed (A)